Business
Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life
(TheNewswire)   Key Highlights   Vision performance: Clinical outcomes e...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life\n(TheNewswire)\n\n\n\n \n\n\nKey Highlights\n\n\n \n\n\n\nVision performance: Clinical\noutcomes exceed expectations, with all patients experiencing\ncontinuing vision improvements  \n\n\n\nSafety profile: Continues to\nmeet expectations  \n\n\n\nQuality-of-life improvements:\nAnecdotally, all patients reported life changing results from\nlens implantations   \n\n\n\nTechnology validation: Results\nreinforce the expected performance of Ocumetics’ inaugural\naccommodating intraocular lens \n\n\n\nMomentum: Forward momentum\ncontinues, with lens design enhancements in manufacturing and testing\nphase \n\n\n\nWebinar: April 22, 2026, 4:00 PM\nET. Register at www.ocumetics.com/webinar \n\n\n\n \n\n\nCalgary, Canada – TheNewswire - April 20, 2026 -\nOcumetics Technology\nCorp. (TSV:V OTC |OTCQB: OTCFF |FRA: 2QBO)\n(“Ocumetics” or the “Company”),\na leader in next generation vision technology,\nis pleased to announce highly encouraging\nsix-month postoperative results from the first\ngroup of patients in its first-in-human (FIH) clinical study of the\nOcumetics Accommodating Intraocular Lens (“Ocumetics\nLens”). \n\n\n \n\n\nSix months after surgery, patients who received the\nOcumetics Lens have achieved clinical outcomes that meet and exceed\nthe Company’s expectations. Group One patients entered the study\nwith very poor vision, including one individual considered to be\nlegally blind. At six months post-surgery, patients continue to\ndemonstrate improved vision and stable visual acuity, alongside a\nstrong safety profile. Patients have also experienced real world\ntransformation in their daily lives. \n\n\n \n\n\n“After six months, what stands out most is not just\nthe clinical performance of the Ocumetics Lens, but the profound\nimpact on patients’ quality of life,” said Dean Burns, President\nand CEO of Ocumetics. “Patients who entered this study with severely\nimpaired vision are now reading, driving, and living independently\nagain. We’re developing a technology that dramatically improves\npeople’s quality of life and we couldn’t be happi...